Adolor Corp - Current report filing (8-K)
May 09 2008 - 2:02PM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) May 9, 2008
Adolor Corporation
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
000-30039
|
|
31-1429198
|
(State or other jurisdiction
Of incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer
Identification No.)
|
|
|
|
700 Pennsylvania Drive, Exton, PA
|
|
19341
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Registrants telephone number, including area code: (484) 595-1500
Not Applicable
(Former name or
former address, if changed since last report)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
On May 9, 2008, Adolor Corporation (the
Company) issued a press release announcing that the U.S. Food and Drug Administration (FDA) has communicated to the Company that it will not be issuing an action letter on the NDA for Entereg® (alvimopan) for postoperative ileus by
May 10, 2008, the scheduled PDUFA date. The FDA did not provide a specific date, but informed the Company that it expects to issue the action letter shortly.
The Company hereby incorporates by reference the press release dated May 9, 2008, attached hereto as Exhibit 99.1, and made a part of this Item 8.01.
Item 9.01
|
Financial Statements and Exhibits.
|
(d)
Exhibits
.
|
|
|
Exhibit No
|
|
Description
|
99.1
|
|
Press release of the Company dated May 9, 2008.
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
|
|
|
ADOLOR CORPORATION
|
|
|
By:
|
|
/s/ Thomas P. Hess
|
Name:
|
|
Thomas P. Hess
|
Title:
|
|
Vice President, Finance, Chief Financial Officer
|
Dated: May 9, 2008
EXHIBIT INDEX
|
|
|
Exhibit No
|
|
Description
|
99.1
|
|
Press release of the Company dated May 9, 2008.
|
Adolor Corp. (MM) (NASDAQ:ADLR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Adolor Corp. (MM) (NASDAQ:ADLR)
Historical Stock Chart
From Jul 2023 to Jul 2024